About RxCelerate

RxCelerate designs and delivers fully integrated drug discovery programmes from concept to clinic. The company combines proprietary platform technologies with scientific expertise across biology, chemistry, antibody discovery, and proteomics to advance both small molecules and biologics. RxCelerate builds complex assays from first principles, enabling clients to tackle challenging targets. The company serves biotech startups, virtual pharma, and established organisations seeking a flexible partner. By offering tailored programme design, RxCelerate accelerates candidate identification through efficient routes. Founded in Cambridge in 2013, the team has contributed to 27 clinical candidates and 16 drugs in the clinic.